🌍 where
Where was the first vaccine for respiratory syncytial virus approved for older adults?
Quick Answer
The first RSV vaccine for older adults was approved in the United States in 2023.
The Full Story
The first respiratory syncytial virus vaccine for older adults was approved in the United States in 2023. RSV is a common virus that can cause severe respiratory illness, especially in infants and older adults. The approval marked a major advance because RSV had long lacked a licensed vaccine despite decades of research. Later approvals expanded protection to more groups, including pregnant people and infants in some countries.
Key Facts
1.Approved in 2023
2.First authorized in the United States
3.Targets severe respiratory infection
YouTube Angle
Suggested video title for this topic:
"After decades of research, the first RSV vaccine arrived in the U.S."
Was this answer helpful?
Tap a reaction — it helps us pick what to cover next.